With artificial intelligence to a diagnosis of rare hereditary diseases: The neural network combines data from portrait images with gene and patient data.
Source: Tori Pantel

AI detects rare diseases

Every year, around half a million children worldwide are born with a rare hereditary disease. Obtaining a definitive diagnosis can be difficult and time consuming. In a study of 679 patients with 105 different rare diseases, scientists from the University of Bonn and the Charité – Universitätsmedizin Berlin have shown that artificial intelligence can be used to diagnose rare diseases more efficiently and reliably. A neural network automatically combines portrait photos with genetic and patient data.

Many patients with rare diseases go through lengthy trials and tribulations until they are correctly diagnosed. “This results in a loss of valuable time that is actually needed for early therapy in order to avert progressive damage,” explains Prof. Dr. med. Dipl. Phys. Peter Krawitz from the Institute for Genomic Statistics and Bioinformatics at the University Hospital Bonn (UKB). Together with an international team of researchers, he demonstrates how artificial intelligence can be used to make comparatively quick and reliable diagnoses in facial analysis.

The researchers used data of 679 patients with 105 different diseases caused by the change in a single gene. These include, for example, mucopolysaccharidosis (MPS), which leads to bone deformation, learning difficulties and stunted growth. Mabry syndrome also results in intellectual disability. All these diseases have in common that the facial features of those affected show abnormalities. This is particularly characteristic, for example, of Kabuki syndrome, which is reminiscent of the make-up of a traditional Japanese form of theatre. The eyebrows are arched, the eye-distance is wide and the spaces between the eyelids are long.

The used software can automatically detect these characteristic features from a photo. Together with the clinical symptoms of the patients and genetic data, it is possible to calculate with high accuracy which disease is most likely to be involved. The AI and digital health company FDNA has developed the neural network DeepGestalt, which the researchers use as a tool of artificial intelligence for their study. “PEDIA is a unique example of next-generation phenotyping technologies,” said Dekel Gelbman, CEO of FDNA. “Integrating an advanced AI and facial analysis framework such as DeepGestalt into the variant analysis workflow will result in a new paradigm for superior genetic testing”.

The scientists trained this computer program with around 30,000 portrait pictures of people affected by rare syndromal diseases. “In combination with facial analysis, it is possible to filter out the decisive genetic factors and prioritize genes,” says Krawitz. “Merging data in the neuronal network reduces data analysis time and leads to a higher rate of diagnosis.”

The head of the Institute of Genomic Statistics and Bioinformatics at the UKB has been working with FDNA for some time. “This is of great scientific interest to us and also enables us to find a cause in some unsolved cases,” said Krawitz. Many patients are currently still looking for an explanation for their symptoms. “Patients want a prompt and accurate diagnosis. Artificial intelligence supports physicians and scientists in shortening the journey,” says Dr. Christine Mundlos, Deputy Managing Director of the alliance of patients with chronic rare diseases (ACHSE) e.V. “This also improves the quality of life of those affected to some extent.”

Subscribe to our newsletter

Related articles

Cardivascular diseases: digital twin improves therapy

Cardivascular diseases: digital twin improves therapy

Using mathematical image processing, scientists have found a way to create digital twins from human hearts.

Precision health in the palm of your hand

Precision health in the palm of your hand

Recent breakthrough developments in technologies for real-time genome sequencing, analysis, and diagnosis are poised to deliver a new standard of personalized care.

An AI companion for lonely seniors

An AI companion for lonely seniors

Scientists are creating chatbots thet can express and respond to emotion during a conversation—including AI companions that could help relieve loneliness for seniors.

Are humans too slow for digitalisation?

Are humans too slow for digitalisation?

Today, drones are happily regarded as the pinnacle of digitalisation in healthcare. However, for Dr Dominik Pförringer, “Drones are not even in the top 100 of my wish list for digital solutions."

AI method can detect precursors to cervical cancer

AI method can detect precursors to cervical cancer

Using AI and mobile digital microscopy, researchers hope to create screening tools that can detect precursors to cervical cancer in women in resource-limited settings.

AI system for the diagnosis of breast cancer

AI system for the diagnosis of breast cancer

Researchers have developed a new tissue-section analysis system for diagnosing breast cancer based on artificial intelligence.

Microfluidics and AI microscopy measure hemoglobin

Microfluidics and AI microscopy measure hemoglobin

Researchers at the Indian Institute of Science and SigTuple Technologies have developed a method to measure hemoglobin levels in small-volume blood samples.

Explainable AI for decoding genome biology

Explainable AI for decoding genome biology

Researchers have developed advanced explainable AI in a technical tour de force to decipher regulatory instructions encoded in DNA.

How genetic motifs conduct "the music of life"

How genetic motifs conduct "the music of life"

​Using AI and supercomputers, researchers have discovered reoccurring patterns and combinations of the four molecular building blocks A, C, G and T.

Popular articles

Subscribe to Newsletter